Clinical Trials in Miami

Showing 3601-3620 of 9,821 trials

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

NCT06389578

The main goal of this study is to learn how teprotumumab will be processed in the body (Pharmacokinetics) subcutaneously and whether it is safe and tolerable after administration into adult patients with thyroid eye disease.

Thyroid Eye Disease

Amgen16 participantsStarted Jul 2022

Miami, Florida, United States • St Louis, Missouri, United States • Bellaire, Texas, United States

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

NCT03719690

An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). The first cohort will assess the objective response rate (ORR) of tipifarnib in subjects with HNSCC with HRAS mutations. The second study cohort, SEQ-HN, is an observational sub-study including HNSCC patients in whom HRAS mutations were not identified (wild type HRAS HNSCC) and who consent to provide first line outcome data and additional follow up.

HRAS Gene MutationHNSCC

Kura Oncology, Inc.296 participantsStarted Mar 2019

Los Angeles, California, United States • Los Angeles, California, United States • San Francisco, California, United States +99 more locations

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

Find Trials by Condition in Miami

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning

Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria